Although FDA highly values the opinions of the independent experts on the committee and often incorporates those opinions into its decision-making process, FDA makes the final decision about whether a drug should be approved.
Eventually, the committee reduced its demand to focus on documents involving decision-making after the administration shut down the Fast and Furious program.
Committees should decide the amount of discretion in investment decision-making given to an outsourcing provider only after the committee has been through a comprehensive review of the range of alternatives.
Rather than scrapping the body, the committee wants its remit to be changed to focus on increasing public access to the system and promoting better decision-making in an effort reduce the number of people seeking redress.